Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$6.79B
Total Bought:
$2.29B
Total Sold:
$1.04B
Net Transaction:
+$1.26B
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Guardant Health, Inc.(GH)3,338,2413,393,312+55,071$308.35M$509.10M7.50%+$200.75M
Immunovant, Inc.(IMVT)11,526,9719,341,151-2,185,820$286.33M$359.91M5.30%+$73.58M
STRUCTURE THERAPEUTICS INC4,279,8484,740,072+460,224$206.29M$254.40M3.75%+$48.11M
Vaxcyte, Inc.(PCVX)4,300,0004,300,0000$249.87M$249.96M3.68%+$86.0K
Alnylam Pharmaceuticals, Inc.(ALNY)0825,000+825,000$0$248.35M3.66%+$248.35M
Veradermics, Incorporated(MANE)500,0002,000,000+1,500,000$31.57M$245.88M3.62%+$214.31M
Tarsus Pharmaceuticals, Inc.(TARS)3,600,0003,666,768+66,768$252.54M$230.79M3.40%-$21.75M
NUVALENT INC1,376,3241,783,322+406,998$141.00M$220.24M3.24%+$79.24M
Alkermes plc(ALKS)3,590,3234,000,000+409,677$126.95M$209.58M3.09%+$82.63M
Ocular Therapeutix, Inc.(OCUL)19,686,28219,686,2820$166.74M$193.32M2.85%+$26.58M
BioMarin Pharmaceutical Inc.(BMRN)1,150,0003,307,481+2,157,481$64.96M$189.25M2.79%+$124.29M
Nurix Therapeutics, Inc.(NRIX)6,345,2447,736,455+1,391,211$98.35M$187.69M2.76%+$89.34M
Oruka Therapeutics, Inc.(ORKA)2,034,2031,926,000-108,203$99.78M$183.30M2.70%+$83.52M
ALUMIS INC6,772,5956,348,558-424,037$149.20M$178.65M2.63%+$29.45M
Ionis Pharmaceuticals, Inc.(IONS)1,950,0002,200,000+250,000$146.43M$174.44M2.57%+$28.01M
COMPASS Pathways plc(CMPS)12,161,49612,161,4960$67.25M$172.09M2.54%+$104.83M
Vera Therapeutics, Inc.(VERA)4,106,0674,000,000-106,067$165.19M$171.64M2.53%+$6.45M
Axsome Therapeutics, Inc.(AXSM)1,100,000700,000-400,000$185.92M$171.34M2.52%-$14.58M
Genmab A/S(GMAB)3,663,2505,650,000+1,986,750$98.28M$155.21M2.29%+$56.92M
MoonLake Immunotherapeutics(MLTX)6,408,8636,999,025+590,162$119.46M$136.27M2.01%+$16.81M
HEMAB THERAPEUTICS HLDGS INC03,602,093+3,602,093$0$132.30M1.95%+$132.30M
Tango Therapeutics, Inc.(TNGX)2,750,0004,200,000+1,450,000$57.53M$131.29M1.93%+$73.76M
Definium Therapeutics, Inc.(DFTX)3,000,0002,750,000-250,000$56.70M$129.36M1.91%+$72.66M
GRAIL, Inc.(GRAL)1,722,7971,834,944+112,147$89.03M$125.27M1.85%+$36.24M
BICARA THERAPEUTICS INC4,062,5004,100,000+37,500$80.80M$121.73M1.79%+$40.93M
Maze Therapeutics, Inc.(MAZE)3,477,5623,732,569+255,007$103.81M$111.38M1.64%+$7.57M
Celldex Therapeutics, Inc.(CLDX)1,283,9792,939,151+1,655,172$40.73M$109.37M1.61%+$68.64M
LB Pharmaceuticals Inc(LBRX)3,352,8043,352,8040$82.68M$108.82M1.60%+$26.14M
MBX Biosciences, Inc.(MBX)2,757,5691,732,569-1,025,000$82.31M$95.64M1.41%+$13.32M
GH Research PLC(GHRS)03,333,334+3,333,334$0$89.60M1.32%+$89.60M
Cogent Biosciences, Inc.(COGT)1,000,0002,000,000+1,000,000$38.49M$77.40M1.14%+$38.91M
ATAIBECKLEY INC12,000,00014,417,442+2,417,442$42.48M$75.98M1.12%+$33.50M
United Therapeutics Corporation(UTHR)0123,616+123,616$0$66.98M0.99%+$66.98M
AVALO THERAPEUTICS INC03,610,000+3,610,000$0$66.71M0.98%+$66.71M
Viridian Therapeutics, Inc.(VRDN)1,393,9443,592,740+2,198,796$27.27M$66.00M0.97%+$38.73M
Cytokinetics, Incorporated(CYTK)1,374,320700,000-674,320$90.58M$59.63M0.88%-$30.95M
ALTIMMUNE INC019,250,000+19,250,000$0$58.52M0.86%+$58.52M
Personalis, Inc.(PSNL)3,000,0004,000,000+1,000,000$19.11M$53.60M0.79%+$34.49M
ACLARIS THERAPEUTICS INC9,345,0009,345,0000$35.04M$49.44M0.73%+$14.39M
CORMEDIX INC6,274,0766,274,0760$42.60M$49.25M0.73%+$6.65M
GeneDx Holdings Corp.(WGS)0700,000+700,000$0$48.05M0.71%+$48.05M
Harrow, Inc.(HROW)0969,000+969,000$0$41.15M0.61%+$41.15M
Corvus Pharmaceuticals, Inc.(CRVS)2,491,5392,491,939+400$36.45M$37.23M0.55%+$778.4K
SOLID BIOSCIENCES INC3,565,0623,565,0620$25.67M$35.61M0.52%+$9.95M
Beam Therapeutics Inc.(BEAM)820,7651,000,000+179,235$19.56M$34.32M0.51%+$14.76M
Dyne Therapeutics, Inc.(DYN)2,000,0001,500,000-500,000$36.26M$33.31M0.49%-$2.94M
IMMIX BIOPHARMA INC02,775,000+2,775,000$0$28.61M0.42%+$28.61M
X4 PHARMACEUTICALS INC6,339,5355,878,757-460,778$26.18M$27.45M0.40%+$1.27M
SHATTUCK LABS INC03,706,734+3,706,734$0$25.72M0.38%+$25.72M
MannKind Corporation(MNKD)06,000,000+6,000,000$0$25.56M0.38%+$25.56M
CENTURY THERAPEUTICS INC9,487,7459,462,645-25,100$21.44M$23.18M0.34%+$1.74M
Generate Biomedicines, Inc.(GENB)01,333,815+1,333,815$0$22.50M0.33%+$22.50M
VERASTEM INC5,740,8505,740,8500$30.43M$21.93M0.32%-$8.50M
Kura Oncology, Inc.(KURA)2,643,5421,978,565-664,977$21.49M$21.70M0.32%+$212.9K
ENANTA PHARMACEUTICALS INC1,956,8671,444,167-512,700$24.72M$21.06M0.31%-$3.66M
Nektar Therapeutics(NKTR)0300,000+300,000$0$20.94M0.31%+$20.94M
OLEMA PHARMACEUTICALS INC01,500,000+1,500,000$0$18.77M0.28%+$18.77M
KAILERA THERAPEUTICS INC0700,000+700,000$0$15.42M0.23%+$15.42M
KARDIGAN INC0600,000+600,000$0$14.31M0.21%+$14.31M
ENLIVEN THERAPEUTICS INC0225,000+225,000$0$11.42M0.17%+$11.42M
PROMIS NEUROSCIENCES INC835,655835,6550$10.61M$11.00M0.16%+$384.4K
Immunocore Holdings plc(IMCR)1,931,884311,218-1,620,666$58.25M$9.88M0.15%-$48.37M
Xencor, Inc.(XNCR)0593,551+593,551$0$9.56M0.14%+$9.56M
CONTEXT THERAPEUTICS INC7,419,3557,419,3550$19.44M$4.11M0.06%-$15.33M
INVENTIVA SA1,222,453800,000-422,453$6.78M$3.02M0.04%-$3.76M
ALIGOS THERAPEUTICS INC444,110444,1100$3.30M$2.56M0.04%-$737.2K
ANI Pharmaceuticals, Inc.(ANIP)600,0000-600,000$46.14M$0—-$46.14M
APELLIS PHARMACEUTICALS INC
COM
4,532,3740-4,532,374$182.34M$0—-$182.34M
APOGEE THERAPEUTICS INC285,0000-285,000$23.99M$0—-$23.99M
BILLIONTOONE INC50,0000-50,000$3.95M$0—-$3.95M
BridgeBio Pharma, Inc.(BBIO)841,4450-841,445$62.49M$0—-$62.49M
CENTESSA PHARMACEUTICALS PLC3,158,0410-3,158,041$125.44M$0—-$125.44M
CRESCENT BIOPHARMA INC.453,6860-453,686$8.33M$0—-$8.33M
CYBIN INC1,313,1370-1,313,137$6.30M$0—-$6.30M
ENGENE HOLDINGS INC
COM
4,377,5720-4,377,572$29.81M$0—-$29.81M
GERON CORP31,720,2780-31,720,278$47.26M$0—-$47.26M
Janux Therapeutics, Inc.(JANX)1,187,2900-1,187,290$16.50M$0—-$16.50M
LARIMAR THERAPEUTICS INC1,500,0000-1,500,000$6.75M$0—-$6.75M
SOLENO THERAPEUTICS INC1,078,7100-1,078,710$36.12M$0—-$36.12M
TERNS PHARMACEUTICALS INC1,073,8770-1,073,877$56.61M$0—-$56.61M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q2 2026 | TickerTrail